The Business of Cannabis

How To Avoid Mistakes When Switching From High Pressure Sodium To Light Emitting Diodes

Oct 1, 2025 | National

Carrying out an Light Emitting Diodes (LED) retrofit of an entire cannabis cultivation facility is certainly a particularly daunting task, albeit necessary at times. There’s always the looming risk that planning and execution mistakes lead to higher operational...

Flawed Data In USDA Hemp Reports Warping Policy, Investment, And Market Signals

Sep 28, 2025 | National

Garbage in, garbage out. It’s a phrase every business person knows, and for good reason: even the most sophisticated decisions are only as good as the data behind them. If the data’s no good, everything else wobbles. I recently took a deep dive into the USDA’s...

California: Governor Signs Legislation Halting Tax Hike On Commercially Available Cannabis Products

Sep 28, 2025 | National

Democratic Gov. Gavin Newsom has signed legislation (Assembly Bill 564) into law halting a recently-enacted excise tax hike on commercially available cannabis products. The law takes effect on October 1st. The new law rolls back a 25 percent tax hike...

Alaska Psychedelics Campaign Launches Signature Drive To Put Legalization Measure On 2026 Ballot

Sep 26, 2025 | National

Alaska activists have officially launched a signature drive to place an initiative on the 2026 ballot to legalize certain psychedelics such as psilocybin and DMT. About a month after the lieutenant governor’s office certified the measure for circulation, a...

Physicians Warn Against Smoking Pot During Pregnancy

Sep 24, 2025 | National

Pregnant women should stay away from cannabis, and doctors should ask all patients about its use before, during and after pregnancy, according to new guidance from the American College of Obstetricians and Gynecologists. The recommendations come as cannabis use during...

White House Exploring All Options For Cannabis Rescheduling, Trump Drug Adviser Nominee Says

Sep 24, 2025 | Feature, National

President Donald Trump’s pick to be the White House’s top drug policy adviser refrained from endorsing a proposed rule to reclassify cannabis from a Schedule I to Schedule III drug under the Controlled Substances Act. That abstention was, in part, because her likely...